Joris van de Haar
0000-0001-5899-3971
Antoni van Leeuwenhoek Nederlands Kanker Instituut
17 papers found
Refreshing results…
The innate immune landscape of dMMR/MSI cancers predicts outcome of nivolumab treatment: results from the Drug Rediscovery Protocol
Efficacy of Pembrolizumab and Biomarker Analysis in Patients with WGS-Based Intermediate to High Tumor Mutational Load: Results from the Drug Rediscovery Protocol
Supplementary Table S4 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer
Supplementary Table S3 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer
Supplementary Figure S3 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer
Supplementary Table S1 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer
Data from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer
Supplementary Figure S2 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer
Supplementary Figure S1 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer
Supplementary Figure S4 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer
Supplementary Table S5 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer
Supplementary Table S2 from Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer
Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
γδ T cells are effectors of immune checkpoint blockade in mismatch repair-deficient colon cancers with antigen presentation defects
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
Missing publications? Search for publications with a matching author name.